Akorn (AKRX) Needs to Divest Generic Injectable Rifampin ANDA in VersaPharm Deal - FTC
Tweet Send to a Friend
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that Akorn's (NASDAQ: AKRX) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE